Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 2, 2022Clinical Drug InvestigationOpen Access

Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects

View Full Paper
Ask AI
Bookmark
Share

Authors

MAMikkel AgersnapZealand Pharma (Denmark)KSKim SonneNovo Nordisk (Denmark)KKKim KnudsenZealand Pharma (Denmark)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Agersnap et al. (2022) studied this question.

synapsesocial.com/papers/69da28b200ab073a27838092https://doi.org/10.1007/s40261-022-01210-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nutrition in Short-Bowel Syndrome1996 · 35 citations
  2. 2Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes2012 · 49 citations
  3. 3Induction of intestinal epithelial proliferation by glucagon-like peptide 2.1996 · 887 citations
  4. 4The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate2016 · 26 citations
  5. 5Gut adaptation and the glucagon-like peptides2002 · 124 citations